[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Batshon et al., 1963 - Google Patents

Immunologic paralysis produced in mice by Klebsiella pneumoniae type 2 polysaccharide

Batshon et al., 1963

Document ID
11988294834621558980
Author
Batshon B
Baer H
Shaffer M
Publication year
Publication venue
The Journal of Immunology

External Links

Snippet

Mice injected with varying amounts of Klebsiella pneumoniae type 2 polysaccharide were subsequently challenged with living homologous organisms after varying intervals of time. Of three preparations of polysaccharide, one was essentially nontoxic and nonimmunizing; …
Continue reading at journals.aai.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Micro-organisms
    • Y10S435/822—Micro-organisms using bacteria or actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from micro-organisms
    • Y10S530/825—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions

Similar Documents

Publication Publication Date Title
Michael et al. Association of" natural" antibodies to gram-negative bacteria with the γ1-macroglobulins
Kim et al. A purified group A streptococcal pyrogenic exotoxin: physicochemical and biological properties including the enhancement of susceptibility to endotoxin lethal shock
Batshon et al. Immunologic paralysis produced in mice by Klebsiella pneumoniae type 2 polysaccharide
Liu et al. The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis
Karakawa et al. Method for the serological typing of the capsular polysaccharides of Staphylococcus aureus
Ziegler et al. Treatment of E. coli and Klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-Gal epimerase-deficient mutant
Schneerson et al. Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.
Morse Isolation and properties of a surface antigen of Staphylococcus aureus
Lancefield Type-specific antigens, M and T, of matt and glossy variants of group A hemolytic streptococci
Schlievert Alteration of immune function by staphylococcal pyrogenic exotoxin type C: possible role in toxic-shock syndrome
Pier Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype 1 Pseudomonas aeruginosa.
Bjornson et al. Biological activities of rabbit immunoglobulin M and immunoglobulin G antibodies to Pseudomonas aeruginosa
Flosdorf et al. Separation of the phase I agglutinogen of H. pertussis from toxic components
Krieger et al. Perinatal immunity to group B β-hemolytic Streptococcus type Ia
Swendsen et al. Humoral immunity to Streptococcus pneumoniae induced by a pneumococcal ribosomal protein fraction
Penn et al. Isolation of a protective, non-toxic capsular antigen from Pasteurella multocida, types B and E
US3674863A (en) Polyvalent immunizing agents and methods for their production
Wiley A new virulence test for Staphylococcus aureus and its application to encapsulated strains
Johns et al. Common enterobacterial antigen: I. Isolation and purification from Salmonella typhosa 0: 901
Austrian Polysaccharide vaccines
Mirick et al. STUDIES ON A NON-HEMOLYTIC STREPTOCOCCUS ISOLATED FROM THE RESPIRATORY TRACT OF HUMAN BEINGS: II. IMMUNOLOGICAL CHARACTERISTICS OF STREPTOCOCCUS MG
Ingram The Conglutination Phenomenon: XIV. The Resistance Enhancing Effect of Conglutinin and Immuno-Conglutinin in Experimental Bacterial Infections
Jones et al. Staphylococcal antibodies in burned patients
Lieberman et al. Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions
Jenkin An antigenic basis for virulence in strains of Salmonella typhimurium